Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge

Reference

• SastrySVNyshadhamJRFixJARecent technological advances in oral drug delivery – a reviewPharm Sci Technolo Today20003413814510754543
   PubMedGoogle Scholar
• HuMLiXBarriers to oral bioavailability – an overviewOral Bioavailability: Basic Principles, Advanced Concepts, and ApplicationsNew YorkJohn Wiley & Sons, Inc2011
   Google Scholar
• HörterDDressmanJInfluence of physicochemical properties on dissolution of drugs in the gastrointestinal tractAdv Drug Deliv Rev2001461758711259834
   PubMedGoogle Scholar
• BackDRogersSReview: first-pass metabolism by the gastrointestinal mucosaAliment Pharmacol Ther1987153393572979678
   PubMedGoogle Scholar
• WilkinsonGRCytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humansJ Pharmacokinet Biopharm19962454754909131486
   PubMedGoogle Scholar
• VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today200712231068107518061887
   PubMed Web of Science ®Google Scholar
• HuangL-FTongW-QTImpact of solid state properties on developability assessment of drug candidatesAdv Drug Deliv Rev200456332133414962584
   PubMed Web of Science ®Google Scholar
• KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm2011420111021884771
   PubMed Web of Science ®Google Scholar
• ZhangLWangSZhangMSunJNanocarriers for oral drug deliveryJ Drug Target201321651552723621127
   PubMed Web of Science ®Google Scholar
• CaiZWangYZhuL-JLiuZ-QNanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugsCurr Drug Metab201011219720720384585
   PubMed Web of Science ®Google Scholar
• NishiokaYYoshinoHLymphatic targeting with nanoparticulate systemAdv Drug Deliv Rev2001471556411251245
   PubMed Web of Science ®Google Scholar
• KumarGPRajeshwarraoPNonionic surfactant vesicular systems for effective drug delivery – an overviewActa Pharm Sin B201114208219
   Web of Science ®Google Scholar
• MoghassemiSHadjizadehANano-niosomes as nanoscale drug delivery systems: an illustrated reviewJ Control Release2014185223624747765
   PubMed Web of Science ®Google Scholar
• HasanAAMadkorHWagehSFormulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery systemDrug Deliv2013203–412012623651102
   PubMed Web of Science ®Google Scholar
• BayindirZSYukselNCharacterization of niosomes prepared with various nonionic surfactants for paclitaxel oral deliveryJ Pharm Sci20109942049206019780133
   PubMed Web of Science ®Google Scholar
• JainSVyasSMannosylated niosomes as adjuvant-carrier system for oral mucosal immunizationJ Liposome Res200616433134517162576
   PubMed Web of Science ®Google Scholar
• RogerELagarceFGarcionEBenoitJ-PBiopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral deliveryNanomedicine20105228730620148639
   PubMed Web of Science ®Google Scholar
• DuanXLiYPhysicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and traffickingSmall201399–101521153223019091
   PubMed Web of Science ®Google Scholar
• HuangY-BTsaiM-JWuP-CTsaiY-HWuY-HFangJ-YElastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechinJ Drug Target201119870971821303222
   PubMed Web of Science ®Google Scholar
• CevcGTransfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug deliveryCrit Rev Ther Drug Carrier Syst1996133–42573889016383
   PubMed Web of Science ®Google Scholar
• ChenYLuYChenJEnhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltInt J Pharm2009376115316019394416
   PubMedGoogle Scholar
• MikovMKevrešanSKuhajdaKJakovljeviæVVasoviæV3a, 7a-Dihydroxy-12-oxo-5b-cholanate as blood-brain barrier permeatorPol J Pharmacol20045636737115215568
   PubMedGoogle Scholar
• BaggerMANielsenHWBechgaardENasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurolEur J Pharm Sci2001141697411457652
   PubMedGoogle Scholar
• MorimotoKNakaiTMorisakaKEvaluation of permeability enhancement of hydrophilic compounds and macromolecular compounds by bile salts through rabbit corneas in-vitroJ Pharm Pharmacol19873921241262435884
   PubMedGoogle Scholar
• GuanPLuYQiJEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomedicine20116965e974
   Google Scholar
• NiuMLuYHovgaardLHypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered doseEur J Pharm Biopharm201281226527222369880
   PubMed Web of Science ®Google Scholar
• ConacherMAlexanderJBrewerJMOral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)Vaccine200119202965297411282208
   PubMedGoogle Scholar
• JungTKammWBreitenbachAKaiserlingEXiaoJKisselTBiodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?Eur J Pharm Biopharm200050114716010840198
   PubMed Web of Science ®Google Scholar
• Harush-FrenkelODebottonNBenitaSAltschulerYTargeting of nanoparticles to the clathrin-mediated endocytic pathwayBiochem Biophys Res Commun20073531263217184736
   PubMed Web of Science ®Google Scholar
• DulinBAbrahamWTPharmacology of carvedilolAm J Cardiol200493936
   Web of Science ®Google Scholar
• MorganTClinical pharmacokinetics and pharmacodynamics of carvedilolClin Pharmacokinet19942653353467914479
   PubMed Web of Science ®Google Scholar
• ICH Guideline Harmonized TripartiteQ2B validation of analytical procedures: methodologyFed Regist199762
   Google Scholar
• DahanAHoffmanAEvaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugsEur J Pharm Sci200524438138815734305
   PubMed Web of Science ®Google Scholar
• ShargelLAndrewBWu-PongSApplied Biopharmaceutics and PharmacokineticsNew YorkMcGraw-Hill2005
   Google Scholar
• RajeraRNagpalKSinghSKMishraDNNiosomes: a controlled and novel drug delivery systemBiol Pharm Bull201134794595321719996
   PubMed Web of Science ®Google Scholar
• HaeriASadeghianSRabbaniSAnvariMSBoroumandMADadashzadehSUse of remote film loading methodology to entrap sirolimus into liposomes: Preparation, characterization and in vivo efficacy for treatment of restenosisInt J Pharm20114141162721554939
   PubMedGoogle Scholar
• BajelanEHaeriAValiAMOstadSNDadashzadehSCo-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistanceJ Pharm Pharm Sci201215456858223106959
   PubMed Web of Science ®Google Scholar
• ManosroiAWongtrakulPManosroiJCharacterization of vesicles prepared with various non-ionic surfactants mixed with cholesterolColloids Surf B Biointerfaces2003301129138
   Web of Science ®Google Scholar
• MokhtarMSammourOAHammadMAMegrabNAEffect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomesInt J Pharm2008361110411118577437
   PubMedGoogle Scholar
• BalakrishnanPShanmugamSLeeWSFormulation and in vitro assessment of minoxidil niosomes for enhanced skin deliveryInt J Pharm200937711819394413
   PubMedGoogle Scholar
• HaoYZhaoFLiNYangYLiKaStudies on a high encapsulation of colchicine by a niosome systemInt J Pharm20022441738012204566
   PubMed Web of Science ®Google Scholar
• HaeriAAlinaghianBDaeihamedMDadashzadehSPreparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumorsIran J Pharm Res201413Suppl324711824
   PubMedGoogle Scholar
• YoshiokaTSternbergBFlorenceATPreparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85)Int J Pharm1994105116
   Web of Science ®Google Scholar
• HaeriASadeghianSRabbaniSAnvariMSErfanMDadashzadehSPEGylated estradiol benzoate liposomes as a potential local vascular delivery system for treatment of restenosisJ Microencapsul2012291839422047547
   PubMed Web of Science ®Google Scholar
• HaeriASadeghianSRabbaniSSirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomesInt J Pharm2013455132033023867987
   PubMedGoogle Scholar
• ChuCTongS-SXuYProliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivoActa Pharmacol Sin201132797398021666703
   PubMed Web of Science ®Google Scholar
• YangLTuckerIGØstergaardJEffects of bile salts on propranolol distribution into liposomes studied by capillary electrophoresisJ Pharm Biomed Anal201156355355921784594
   PubMed Web of Science ®Google Scholar
• El-RidyMSAbdelbaryANasrEANiosomal encapsulation of the antitubercular drug, pyrazinamideDrug Dev Ind Pharm20113791110111821417612
   PubMed Web of Science ®Google Scholar
• AkhterSKushwahaSWarsiMHDevelopment and evaluation of nanosized niosomal dispersion for oral delivery of GanciclovirDrug Dev Ind Pharm2012381849221726136
   PubMed Web of Science ®Google Scholar
• Sezgin-BayindirZOnay-BesikciAVuralNYukselNNiosomes encapsulating paclitaxel for oral bioavailability enhancement: preparation, characterization, pharmacokinetics and biodistributionJ Micro-encapsul2013308796804
   PubMed Web of Science ®Google Scholar
• AndrieuxKForteLLesieurSPaternostreMOllivonMGrabielle-MadelmontCSolubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile saltEur J Pharm Biopharm200971234635518835441
   PubMed Web of Science ®Google Scholar
• SunJDengYWangSCaoJGaoXDongXLiposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluationDrug Deliv201017316417020196698
   PubMed Web of Science ®Google Scholar
• HumberstoneAJCharmanWNLipid-based vehicles for the oral delivery of poorly water soluble drugsAdv Drug Deliv Rev1997251103128
   Web of Science ®Google Scholar
• JangaKYJukantiRVelpulaABioavailability enhancement of zaleplon via proliposomes: Role of surface chargeEur J Pharm Biopharm201280234735722041602
   PubMed Web of Science ®Google Scholar
• JadonPSGajbhiyeVJadonRSGajbhiyeKRGaneshNEnhanced oral bioavailability of griseofulvin via niosomesAAPS Pharm Sci Tech200910411861192
   PubMed Web of Science ®Google Scholar
• El-ShabouriMPositively charged nanoparticles for improving the oral bioavailability of cyclosporin-AInt J Pharm2002249110110812433438
   PubMedGoogle Scholar
• LianTHoRJTrends and developments in liposome drug delivery systemsJ Pharm Sci200190666768011357170
   PubMed Web of Science ®Google Scholar